Skip to main content

Unable to load price data. Sorry.


Juniper Pharmaceuticals, Inc. (NASDAQ:CBRX)

CAPS Rating: No stars

The Company is engaged in the research, development, and commercialization of women's healthcare and endocrinology products, including those that treat and are intended to treat infertility, endometriosis, dysmenorrhea and hormonal deficiencies.

Unable to load market data for this Ticker. Sorry.



How do you think NASDAQ:CBRX will perform against the market?

Add Stock to CAPS Watchlist

All Players

64 Outperform
12 Underperform

All-Star Players

3 Outperform
5 Underperform

Wall Street

0 Outperform
0 Underperform

Top NASDAQ:CBRX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

figglebird (71.69)
Submitted April 15, 2012

Odds are better than blackjack... substantially...

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

Recent Community Commentary

Read the most recent pitches from players about CBRX.


Member Avatar figglebird (71.69) Submitted: 4/14/2012 8:52:31 PM : Outperform Start Price: $5.48 NASDAQ:CBRX Score: -142.41

Odds are better than blackjack... substantially...


Member Avatar rinchenmtp (< 20) Submitted: 8/9/2011 3:45:48 PM : Outperform Start Price: $19.76 NASDAQ:CBRX Score: -224.60

CBRX will get FDA approval for its PROCHIEVE® Vaginal Progesterone Gel by the end of February. Watson must pay CBRX a $5,000,000 milestone payment and will sell the drug.

Prochieve will allow women with short cervix's a 90% chance of bringing their pregnancy to term. As opposed to overwhelming amount of pre-mature births for women with cervical lengths of 2.5cm and smaller.

Also, I believe that Prochieve will be used on all woman regardless of the cervical length given the litigious problems for Dr's in the maternity field.

I see a target price of around $5-$7 around Feb. 2012.

Worst case scenario, CBRX gets bought by Watson.


Member Avatar XMFAllumbrado (< 20) Submitted: 7/27/2011 10:47:46 PM : Outperform Start Price: $23.44 NASDAQ:CBRX Score: -260.65

By Feb 2012 the FDA should approve the progesterone gel that will prevent premature births for women with small cervix's. I believe that it will become a standard practice to use on all pregnant women. Dr.'s do not want to get sued, and insurance companies will pay.


Find the members with the highest scoring picks in CBRX.

Score Leader


JackOffBadApples (63.70) Score: +288.44

The Score Leader is the player with the highest score across all their picks in CBRX.

Member Name Member
Call Time
Score Commentary
JackOffBadApples 63.70 9/12/2008 Underperform 3W $26.16 -71.87% +216.57% +288.44 0 Comment
schwah5 78.46 7/30/2008 Underperform NS $32.64 -77.45% +209.81% +287.26 0 Comment
ScreenerStizBear 49.67 6/26/2008 Underperform NS $27.44 -73.18% +205.33% +278.51 1 Comment
SwMad 93.07 1/3/2007 Underperform 3W $40.88 -82.00% +184.60% +266.60 0 Comment
cecamadocv4 98.40 12/22/2010 Underperform 5Y $17.04 -56.81% +203.76% +260.57 0 Comment
Maribaza 97.55 12/16/2010 Underperform 5Y $14.88 -50.54% +205.87% +256.41 1 Comment
RafaelStockNegat 96.24 8/5/2010 Underperform 5Y $7.76 -5.15% +238.54% +243.70 0 Comment
hmarkguy < 20 5/15/2007 Underperform 5Y $18.31 -59.80% +166.75% +226.55 0 Comment
BDK34 90.30 5/22/2007 Underperform 3Y $19.12 -61.51% +164.08% +225.58 0 Comment
raisethesky 35.01 9/26/2007 Underperform NS $19.36 -61.98% +162.47% +224.46 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CBRX.